Blood-based proteomic profiling of 251 inflammatory proteins in 543 newly diagnosed patients with acute myeloid leukemia (AML) identified an eight-protein signature that enhances risk stratification.

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive ...

However, it has proven difficult to identify such specific antigens in certain cancer types, including acute myeloid leukemia (AML ... receptor (CAR)-based therapy for AML.

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive ...

Promising Cell Therapy Offers Hope for Relapsed or ... team of scientists has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth. AML cells prevent the ...

Master Trial is at the heart of LLS's Dare to Dream Project to transform treatment and care for kids with blood cancer WASHINGTON, April 21, 2025 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) ...

In Acute Myeloid Leukemia (AML), the bone marrow makes abnormal myeloblasts (a type of white blood ... Our researchers continue to lead the way in harnessing this power to treat patients with leukemia ...

CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to ...

("Exicure") is planning for a clinical trial in Acute Myeloid Leukemia (AML ... and cell and gene therapy settings. About Exicure, Inc. Exicure, Inc. has historically been an early-stage ...